CEVHEROĞLU, O. Et Al. 2023. Downstream signalling of the disease-associated mutations on GPR56/ADGRG1.. Basic & clinical pharmacology & toxicology , vol.133, no.4 , 331-341.

CEVHEROĞLU, O., Demir, N., KESİCİ, M. S., ÖZÇUBUKÇU, S., & SON, Ç. D., (2023). Downstream signalling of the disease-associated mutations on GPR56/ADGRG1.. Basic & clinical pharmacology & toxicology , vol.133, no.4, 331-341.

CEVHEROĞLU, ORKUN Et Al. "Downstream signalling of the disease-associated mutations on GPR56/ADGRG1.," Basic & clinical pharmacology & toxicology , vol.133, no.4, 331-341, 2023

CEVHEROĞLU, ORKUN Et Al. "Downstream signalling of the disease-associated mutations on GPR56/ADGRG1.." Basic & clinical pharmacology & toxicology , vol.133, no.4, pp.331-341, 2023

CEVHEROĞLU, O. Et Al. (2023) . "Downstream signalling of the disease-associated mutations on GPR56/ADGRG1.." Basic & clinical pharmacology & toxicology , vol.133, no.4, pp.331-341.

@article{article, author={ORKUN CEVHEROĞLU Et Al. }, title={Downstream signalling of the disease-associated mutations on GPR56/ADGRG1.}, journal={Basic & clinical pharmacology & toxicology}, year=2023, pages={331-341} }